Neurometabolic Disorders: Potentially Treatable Abnormalities in Patients With Treatment-Refractory Depression and Suicidal Behavior
Has this study been replicated?
The atlas records 1 replication of this study. Recorded outcomes: 1 successful. The earliest on record is from 2022.
Replications
- Metabolomic disorders: confirmed presence of potentially treatable abnormalities in patients with treatment refractory depression and suicidal behavior, Pan et al. (2022). Psychological Medicine. Outcome recorded: successful.
Examination of metabolic disorders in treatment refractory depression identified an unexpectedly large proportion of patients with potentially treatable abnormalities.
Outcome read from the abstract. View paper
Cite this record
Pan, L. A., Martin, P., Zimmer, T., Segreti, A. M., Kassiff, S., McKain, B. W., Baca, C. A., Rengasamy, M., Hyland, K., Walano, N., Steinfeld, R., Hughes, M., Dobrowolski, S. K., Pasquino, M., Diler, R., Perel, J., Finegold, D. N., Peters, D. G., Naviaux, R. K., … Vockley, J. (2017). Neurometabolic Disorders: Potentially Treatable Abnormalities in Patients With Treatment-Refractory Depression and Suicidal Behavior. American Journal of Psychiatry, 174(1), 42–50. https://doi.org/10.1176/appi.ajp.2016.15111500
Other studies in the atlas
Failed replications · Successful replications · All browse pages